SYNTHON HISPANIA SL
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about SYNTHON HISPANIA SL
Live alerts from global media, monitored by Business Radar
2024-01-19 (cnbctv18.com)
Zydus Life signs exclusive licensing and supply agreement for breast cancer drug
Synthon will be responsible for obtaining the US regulatory approval for the Palbociclib tablets and thereafter for the manufacturing and supply of the product.
Read more